LEADER 01939nam 2200529Ia 450 001 9910451489403321 005 20200520144314.0 035 $a(CKB)1000000000450536 035 $a(OCoLC)58596199 035 $a(CaPaEBR)ebrary10071987 035 $a(SSID)ssj0000096384 035 $a(PQKBManifestationID)11122291 035 $a(PQKBTitleCode)TC0000096384 035 $a(PQKBWorkID)10076849 035 $a(PQKB)11496788 035 $a(MiAaPQ)EBC3377668 035 $a(Au-PeEL)EBL3377668 035 $a(CaPaEBR)ebr10071987 035 $a(OCoLC)883573254 035 $a(EXLCZ)991000000000450536 100 $a20050324d2003 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAccelerating the research, development, and acquisition of medical countermeasures against biological warfare agents$b[electronic resource] $einterim report /$fCommittee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents 210 $aWashington, D.C. $cNational Academies Press$dc2003 215 $a1 online resource (18 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-309-58259-8 320 $aIncludes bibliographical references. 606 $aBiological weapons$xHealth aspects 606 $aToxicology 608 $aElectronic books. 615 0$aBiological weapons$xHealth aspects. 615 0$aToxicology. 676 $a615.9 712 02$aInstitute of Medicine (U.S.).$bMedical Follow-up Agency. 712 02$aInstitute of Medicine (U.S.).$bBoard on Life Sciences. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910451489403321 996 $aAccelerating the research, development, and acquisition of medical countermeasures against biological warfare agents$92036561 997 $aUNINA